Calls for papers
-
The Bill and Melinda Gates Foundation has awarded a $2.5 million grant to researchers at Liverpool School of Tropical Medicine (LSTM) for a study to determine the effects of nasal spray flu vaccine on pneumococcal… Read more . . .
-
According to Avanir Pharmaceuticals,the FDA has issued a Discipline Review letter in response to the company’s NDA for AVP-825 intranasal dry powder sumatriptan requesting that the company “optimize the product-user interface” and conduct additional human… Read more . . .
-
The Australian Research Council has awarded a $521,800 grant to Daniela Traini and Paul Young of the Woolcock Institute’s RespiTech group and Patrick Spicer of the University of New South Wales for development of inhalable… Read more . . .
-
As AstraZeneca completes the acquisition of Almirall’s respiratory drug franchise, which was first announced in July 2014, Almirall says that 719 employees will transfer to AstraZeneca. The deal includes the inhalation R&D company Almirall Sofotec… Read more . . .
-
Impax Laboratories has reported a 19.1% increase in total revenues for the quarter ended September 30, 2014 compared to the third quarter of the prior year. The company attributes a portion of the increase in… Read more . . .
-
Danish instrument manufacturer Ametek Test & Calibration Instruments says that it has worked with “a leading pharmaceutical manufacturer” to develop a semi-automated tester that “detects the firing load and valve breakdown load of one-shot, pressurized… Read more . . .
-
Accordig to Sandoz, the company has received marketing authorization in Estonia, Latvia and Lithuania for the 50-250 and 50-500 µg dosages of the AirFluSal Forspiro salmeterol/fluticasone DPI for the treatment of asthma and COPD. The… Read more . . .
-
Bristol-Myers Squibb could pay a total of up to $444 million to acquire Galecto Biotech and its TD139 inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), plus potential milestones. The newly announced… Read more . . .
-
Texas-based Mystic Pharmaceuticals has announced that its new Arrowfish intranasal delivery system is now available. The platform, which incorporates Mystic’s VersiDoser and VRx2 blister systems, can deliver either liquid or dry powder formulations, in either… Read more . . .
-
Discovery Laboratories, which is developing Aerosurf aerosolized KL4 surfactant for the treatment of respiratory distress syndrome (RDS) in premature infants, has announced several management changes. Steven G. Simonson, who joined the company in May 2014,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK